Wy 41770

Known as: Wy-41,770, Wy-41770 
 

Topic mentions per year

Topic mentions per year

1984-1988
01219841988

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1988
1988
The intestinal ulcerogenic activity of the weak prostaglandin synthesis inhibitor drug Wy-41,770 [5H-dibenzo(a,d)-cyclohepten-5… (More)
Is this relevant?
1986
1986
The disposition of (5H-dibenzo[a,d]cyclohepten-5-ylidene)acetic acid (Wy-41,770), an anti-inflammatory agent, was investigated in… (More)
Is this relevant?
1986
1986
The immunomodulatory effects of Wy-41,770 (5H-dibenzo[a,d]cyclohepten-5-ylidene) acetic acid, were compared to levamisole and… (More)
Is this relevant?
1984
1984
Utilizing an adjuvant arthritis model in rats, we examined humoral immunity to collagen and inflammation in animals with active… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1984
1984
Wy-41,770 [(5H-dibenzo[a,d]cyclohepten-5-ylidene)acetic acid], a novel acrylic acid, was compared to indomethacin and aspirin in… (More)
  • figure I
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?